(Q70555080)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference

B A Mueller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

S K Scarim

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

W L Macias

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

172-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

The biotransformation of drugs in renal failure

12 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Renal disease and drug metabolism: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

The rate of procaine hydrolysis in serum of normal subjects and diseased patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Antimicrobial agents in adult patients with renal insufficiency: initial dosage and general recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Guide to drug dosage in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Clinical pharmacokinetics of antibiotics in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Antimicrobial therapy in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of imipenem and cilastatin in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of Imipenem/Cilastatin during Continuous Arteriovenous Hemofiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Continuous arteriovenous hemofiltration in acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

Pharmacokinetics of vancomycin in patients with various degrees of renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981089-4

7 January 2021

10.1016/S0272-6386(12)81089-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8430678%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference